Chronix closes in on $1.7M for chronic disease diagnosis
Chronix Biomedical, maker of various products used to detect and diagnose chronic diseases, has almost completed its $1.7 million round of equity, according to a filing with the SEC. Based in San Jose, Calif., the company is backed by Pentagram Partners and PrairieGold Venture Partners.
Diagnostics firm Chronix busts out of stealth, looks for cash
Chronix Biomedical, a diagnostic test development company that has operated mostly in secret since its 2000 inception, has finally come out of its shell — publishing information on its product in three academic journals and announcing its push for commercialization. To fuel the latter, it has already secured $845,000 in a third round of venture funding but hopes to rack up at least $2 or $3 million before the close of the round, VentureWire reports.
The… Continue Reading
Stealth startup Chronix Biomedical raises $2.27M
San Jose, Calif.-based Chronix is working on means to detect and monitor chronic diseases. It has raised a small $2.27 million second round from Pentagram Partners LP, PrairieGold Venture Partners and individual investors, VentureWire reports.